Diagnostic accuracy of the novel and biosafe molecular assay Orange G3 TBC compared to GeneXpert for tuberculosis diagnosis in resource-limited settings

dc.contributor.authorJ C Garberi
dc.contributor.authorGabriel Estryk
dc.contributor.authorRichard Chiara
dc.contributor.authorPatricia Callisperis
dc.contributor.authorPatricia Loza
dc.contributor.authorLuis Scigliano
dc.contributor.authorSandra Andrea Casevecchie
dc.contributor.authorJuan Ezequiel Garberi
dc.contributor.authorEdgar Villarte
dc.contributor.authorMike Acevedo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:47:27Z
dc.date.available2026-03-22T19:47:27Z
dc.date.issued2025
dc.description.abstractThe Orange G3 TBC platform offers comparable diagnostic accuracy to GeneXpert Ultra. The system is adaptable to resource-limited settings, making it a viable alternative for TB diagnosis in endemic regions.
dc.identifier.doi10.1177/20499361251386681
dc.identifier.urihttps://doi.org/10.1177/20499361251386681
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78136
dc.language.isoen
dc.publisherSAGE Publishing
dc.relation.ispartofTherapeutic Advances in Infectious Disease
dc.sourceUniversidad de Buenos Aires
dc.subjectGeneXpert MTB/RIF
dc.subjectMedicine
dc.subjectDiagnostic accuracy
dc.subjectTuberculosis
dc.subjectTuberculosis diagnosis
dc.subjectOrange (colour)
dc.subjectDiagnostic test
dc.titleDiagnostic accuracy of the novel and biosafe molecular assay Orange G3 TBC compared to GeneXpert for tuberculosis diagnosis in resource-limited settings
dc.typearticle

Files